Exela Pharma Company Profile
✉ Email this page to a colleague
What is the competitive landscape for EXELA PHARMA, and what generic alternatives to EXELA PHARMA drugs are available?
EXELA PHARMA has twenty-three approved drugs.
There are sixteen US patents protecting EXELA PHARMA drugs.
Summary for Exela Pharma
| US Patents: | 16 |
| Tradenames: | 20 |
| Ingredients: | 20 |
| NDAs: | 23 |
| Patent Litigation for Exela Pharma: | See patent lawsuits for Exela Pharma |
Drugs and US Patents for Exela Pharma
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Exela Pharma | NIPRIDE RTU IN SODIUM CHLORIDE 0.9% | sodium nitroprusside | SOLUTION;INTRAVENOUS | 209387-003 | Jul 13, 2018 | AP | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Exela Pharma | DILTIAZEM HYDROCHLORIDE IN DEXTROSE 5% | diltiazem hydrochloride | SOLUTION;INTRAVENOUS | 215252-002 | Oct 28, 2021 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
| Exela Pharma | BLOXIVERZ | neostigmine methylsulfate | SOLUTION;INTRAVENOUS | 204078-001 | May 31, 2013 | AP | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Exela Pharma | GLYRX-PF | glycopyrrolate | SOLUTION;INTRAMUSCULAR, INTRAVENOUS | 210997-004 | Dec 14, 2020 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | |||||
| Exela Pharma | ELCYS | cysteine hydrochloride | SOLUTION;INTRAVENOUS | 210660-002 | Dec 4, 2023 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
| Exela Pharma | SODIUM BICARBONATE | sodium bicarbonate | INJECTABLE;INJECTION | 211091-001 | Jun 20, 2019 | AP | RX | No | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Exela Pharma | ELCYS | cysteine hydrochloride | SOLUTION;INTRAVENOUS | 210660-001 | Apr 16, 2019 | RX | Yes | Yes | 11,826,383 | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
